POLYMED - IntraDay Trade Analysis with Live Signals

Last Updated Time : 19 Sept 25, 2:16 pm

IntraDay Trade Rating: 3.6

🩺 Intraday Trading Analysis for POLYMED (Poly Medicure Ltd)

📊 Technical & Momentum Overview

Current Price: ₹2,065 — trading slightly above 50 DMA (₹2,052) but below 200 DMA (₹2,188), indicating a short-term bounce within a broader consolidation.

RSI at 55.6: Mild bullish momentum, with room to rise before overbought territory.

MACD at -4.09: Still negative, suggesting caution despite price strength.

Volume: 4.42L vs 2.03L average — significantly above average, indicating strong intraday interest and potential for price action.

📈 Fundamental Snapshot

P/E of 60.3 vs Industry PE of 50.1: Slightly overvalued.

ROCE (18.2%) & ROE (14.2%): Healthy operational efficiency.

Quarterly PAT Growth: ₹86.7 Cr → ₹87.9 Cr — stable earnings.

PEG Ratio of 1.95: Fairly valued relative to growth.

Institutional Activity: FII (-0.05%) and DII (-0.24%) reduced holdings — neutral to mildly negative.

Debt-to-Equity (0.06): Excellent financial structure.

🎯 Intraday Strategy

✅ Optimal Buy Price

Buy Zone: ₹2,050–₹2,060

Entry near 50 DMA with tight stop-loss; confirm with MACD flattening and RSI holding above 54.

💰 Profit-Taking Levels

Target 1: ₹2,085 (minor resistance)

Target 2: ₹2,110 (next resistance zone)

Aggressive Target: ₹2,135+ only if RSI crosses 60 and MACD turns positive

🛡️ Stop-Loss

Stop-Loss Level: ₹2,030

Breach below this level signals breakdown risk and invalidates intraday setup.

🕒 Exit Strategy If Already Holding Today

Exit on Strength

If price nears ₹2,110–₹2,135 and RSI rises above 60 with volume surge, consider booking profits.

Exit on Weakness

If MACD continues to decline and price fails to hold ₹2,050, exit to avoid deeper downside.

Volume drop below 3.5L with price rejection at ₹2,085 is a strong exit signal.

POLYMED offers a moderately favorable setup for intraday trading today, especially if price sustains above ₹2,050 and volume remains strong. Let me know if you'd like to track this live or compare with other healthcare sector stocks showing stronger momentum.

Edit in a page